114 related articles for article (PubMed ID: 34190419)
1. Bioequivalence for a Fixed-Dose Combination Formulation of Bazedoxifene and Cholecalciferol Compared With the Corresponding Single Entities Given Together.
Yun JN; Kan HS; Yeun JS; Kim JH; Lee M; Kim N; Oh TY; Nam SK; Choi YS; Kwon IS; Hoe KL; Hong JH
Clin Pharmacol Drug Dev; 2021 Aug; 10(8):850-858. PubMed ID: 34190419
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.
Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; La S; Kim HJ; Cho S; Yoon YR; Yang DH; Lee HW
Drug Des Devel Ther; 2018; 12():545-553. PubMed ID: 29559771
[TBL] [Abstract][Full Text] [Related]
3. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
Park SI; Lee H; Oh J; Lim KS; Jang IJ; Kim JA; Jung JH; Yu KS
Drug Des Devel Ther; 2015; 9():729-36. PubMed ID: 25678778
[TBL] [Abstract][Full Text] [Related]
4. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence of sitagliptin/metformin fixed-dose combination tablets and concomitant administration of sitagliptin and metformin in healthy adult subjects: a randomized, open-label, crossover study.
Migoya EM; Miller JL; Gutierrez M; Zheng W; Johnson-Levonas AO; Liu Q; Matthews CZ; Wagner JA; Gottesdiener KM
Clin Drug Investig; 2010; 30(12):855-66. PubMed ID: 20923244
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence, Food Effect, and Steady-State Assessment of Dapagliflozin/Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects.
Chang M; Liu X; Cui D; Liang D; LaCreta F; Griffen SC; Lubin S; Quamina-Edghill D; Boulton DW
Clin Ther; 2015 Jul; 37(7):1517-28. PubMed ID: 26048185
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence Study of a New Fixed-dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects.
Oh MJ; Hwang HH; Kim HG; Lee GH; Cho YS; Lee SY; Kang SY; Cho KH; Lee YY; Lee YJ; Jang CG; Lee SY
Clin Ther; 2017 Jul; 39(7):1371-1379. PubMed ID: 28625505
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions.
Wu L; Xu C; Wu G; Zhou H; Lv D; Zhai Y; Huang Y; Tang W; Li F; Shentu J
Drug Des Devel Ther; 2019; 13():3331-3342. PubMed ID: 31571834
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic Variables of Dapagliflozin/Metformin Extended-release Fixed-dose Combination in Healthy Chinese Volunteers and Regional Comparison.
Zhao X; Ning R; Hui A; Boulton DW; Tang W
Clin Ther; 2023 Aug; 45(8):762-769. PubMed ID: 37442656
[TBL] [Abstract][Full Text] [Related]
10. Fixed-dose combination tablet of repaglinide and metformin is bioequivalent to concomitantly administered individual tablets of repaglinide and metformin : randomized, single-blind, three-period crossover study in healthy subjects.
Hoelscher D; Chu PL; Lyness W
Clin Drug Investig; 2008; 28(9):573-82. PubMed ID: 18666804
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers.
Liu MY; Wang S; Yao WF; Wu HZ; Meng SN; Wei MJ
Clin Ther; 2009 Apr; 31(4):784-92. PubMed ID: 19446151
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic properties of single-dose lamivudine/adefovir dipivoxil fixed-dose combination in healthy Chinese male volunteers.
Fok BS; Gardner S; Piscitelli S; Chen S; Chu TT; Chan JC; Tomlinson B
Clin Ther; 2013 Jan; 35(1):68-76. PubMed ID: 23274144
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence and food effect of a fixed-dose combination of macitentan and tadalafil: Adaptive design in the COVID-19 pandemic.
Csonka D; Fishman V; Natarajan J; Stieltjes H; Armas D; Dishy V; Perez Ruixo JJ
Pharmacol Res Perspect; 2021 Oct; 9(5):e00846. PubMed ID: 34624174
[TBL] [Abstract][Full Text] [Related]
14. A Phase I Study to Show the Relative Bioavailability and Bioequivalence of Fixed-Dose Combinations of Ambrisentan and Tadalafil in Healthy Subjects.
Okour M; Puri A; Chen G; Port K; Berni A; Khindri S; Schneider I; Tenero D
Clin Ther; 2019 Jun; 41(6):1110-1127. PubMed ID: 31060740
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic Interactions Between Bazedoxifene and Cholecalciferol: An Open-Label, Randomized, Crossover Study in Healthy Male Volunteers.
Lee MH; Yoon SK; Kim H; Cho YS; Han S; Lee SH; Bae KS; Jung J; Hong SH; Lim HS
Drug Des Devel Ther; 2023; 17():1107-1114. PubMed ID: 37077410
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic Equivalence of the High Dose Strength Fixed-Dose Combination Tablet of Gemigliptin/Metformin Sustained Release (SR) and Individual Component Gemigliptin and Metformin XR Tablets in Healthy Subjects.
Cho YS; Lee SH; Lim HS; Bae KS
J Korean Med Sci; 2018 Oct; 33(41):e258. PubMed ID: 30288156
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and relative bioavailability of fixed-dose combination of clopidogrel and aspirin versus coadministration of individual formulations in healthy Korean men.
Choi HK; Ghim JL; Shon J; Choi YK; Jung JA
Drug Des Devel Ther; 2016; 10():3493-3499. PubMed ID: 27822013
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects.
Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; Cho S; Shim WS; Lee KT; Kim EH; Yang DH; Lee HW; Yoon YR
Drug Des Devel Ther; 2018; 12():3607-3615. PubMed ID: 30464392
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the pharmacokinetics, safety, and tolerability of vitamin D3 in DP-R206 (150-mg ibandronate/24,000-IU vitamin D3 tablet) and as monotherapy (24,000 iu) in healthy male Korean adults.
Jeon JY; Lee SY; Im YJ; Kim EY; Kim Y; Park TS; Chae SW; Lee JW; Jun H; Lee TW; Kim MG
Clin Ther; 2014 Jan; 36(1):48-57. PubMed ID: 24378207
[TBL] [Abstract][Full Text] [Related]
20. Investigation of bioequivalence, safety, and tolerability of a fixed-dose combination of nifedipine GITS and candesartan compared with the corresponding loose-dose combination under fed conditions
.
Thomas D; Liu Y; Stein H; Weimann B
Int J Clin Pharmacol Ther; 2019 Aug; 57(8):420-428. PubMed ID: 31232274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
